Compass Therapeutics Inc. Dividends
The next dividend date for Compass Therapeutics Inc. has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Compass Therapeutics Inc. (CMPX)
More About Compass Therapeutics Inc.
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in the development of antibody-based therapeutics for the treatment of various human diseases in the United States. The company's lead product candidates include tovecimig, a bispecific antibody that blocks Delta-like ligand 4 (DLL4) and vascular endothelial growth factor A (VEGF-A) signaling pathways, which are critical to angiogenesis and tumor vascularization; CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137, a key co-stimulatory receptor on immune cells; and CTX-8371, a bispecific inhibitor that targets programmed cell death protein-1 (PD-1) and ligand PD-L1 checkpoint inhibitor antibodies. It also develops CTX-10726, a bispecific antibody that targets PD-1 and VEFG-A; and VEGF-IO Bispecific / Multiple, a bispecific antibody engages the angiogenesis pathway and anti-tumor immune that targets, including immune checkpoints, as well as analyzes VEGF combinations with other immune response-related proteins. Compass Therapeutics, Inc. was founded in 2014 and is headquartered in Boston, Massachusetts.
Owning Compass Therapeutics Inc. Stock on the Dividend Date
If you own Compass Therapeutics Inc. stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Compass Therapeutics Inc. stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Compass Therapeutics Inc. stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Compass Therapeutics Inc. stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Compass Therapeutics Inc. dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Compass Therapeutics Inc. Dividends
You can contact us any time if you would like to ask questions about Compass Therapeutics Inc. dividends or anything else related to the stock market.